Therefore, the objective of the present study was to compare the diagnostic performances of NKA-IFNγ to other tumor markers (serum CEA and CA19-9) in GC patients and examine the correlation between tumor markers and clinicopathologic parameters. Here, CEACAM5 is linked to gastric cancer.